Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for ovarian cancer].

T Bjørge1, A Dørum, C G Tropé

  • 1Avdeling for gynekologisk onkologi, Det Norske Radiumhospital, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|June 14, 2000
PubMed
Summary

Screening for ovarian cancer may improve survival rates, especially for high-risk individuals. However, current screening methods lack sufficient sensitivity and specificity for widespread early detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial.

Gynecologic oncology·2020
Same author

The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence.

Journal of internal medicine·2018
Same author

HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.

Gynecologic oncology·2017
Same author

Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study.

British journal of cancer·2016
Same author

Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era".

Gynecologic oncology·2014
Same author

Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).

European journal of cancer (Oxford, England : 1990)·2014

Area of Science:

  • Oncology
  • Gynecologic Oncology
  • Preventive Medicine

Background:

  • Ovarian cancer remains a significant health challenge in developed nations, with a five-year survival rate around 40% despite treatment advancements.
  • The prognosis for ovarian cancer is heavily influenced by the stage at diagnosis, highlighting the importance of early detection.

Discussion:

  • Ovarian cancer presents challenges for screening due to the absence of a detectable preclinical stage and limitations in test sensitivity and specificity.
  • While direct evidence of mortality reduction through screening is lacking, emerging data suggest potential survival benefits.

Key Insights:

  • Early detection of ovarian cancer is crucial, as prognosis is strongly stage-dependent.
  • Current screening tests for ovarian cancer are not fully effective due to limitations in sensitivity and specificity.
  • Screening may offer survival advantages, particularly for women with a higher risk of developing ovarian cancer.

Outlook:

  • Further research is needed to develop more sensitive and specific screening tools for ovarian cancer.
  • Targeted screening approaches for high-risk populations may be a viable strategy for improving ovarian cancer outcomes.
  • Continued investigation into the impact of screening on ovarian cancer mortality is warranted.

Related Experiment Videos